GSC
IPXL

Ground Swell Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Ground Swell Capital’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$30K Buy
1,276
+351
+38% +$8.99K 0.06% 374
2014
Q2 		$28K Buy
+925
New +$25K 0.05% 299

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ground Swell Capital's IPXL Position: Q3 2014 in Review

Ground Swell Capital increased its Impax Laboratories, Inc. (IPXL) stake by 38% in Q3 2014, buying an estimated $8.99K and bringing the position to 1,276 shares worth $30K. The position accounts for 0.06% of the portfolio, ranked #374.

Ground Swell Capital first reported a position in IPXL in Q2 2014 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold IPXL as of Q3 2014.

  • Ground Swell Capital held 1,276 shares of Impax Laboratories, Inc. worth $30K as of Q3 2014.
  • Ground Swell Capital bought 351 Impax Laboratories, Inc. shares in Q3 2014, an estimated $8.99K.
  • Impax Laboratories, Inc. made up 0.06% of Ground Swell Capital's portfolio in Q3 2014, its #374 holding.
  • Ground Swell Capital first reported a position in Impax Laboratories, Inc. in Q2 2014 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.